Répertoire du corps professoral

Financements des 2 dernières années

Clinical validity and clinical utility of a screening test for Paget's disease of bone
Programme: Subvention Projet
Organisme(s) subventionnaire(s): Instituts de recherche en santé du Canada
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 mars 2019 au 31 mars 2023

Encadrements terminés dans les 5 dernières années

Claudia Beaudoin, Doctorat en épidémiologie

Publications des 5 dernières années

Bone Turnover Markers Predict Changes in Bone Mineral Density in Men Treated with Abaloparatide: Results from ATOM Journal of Bone and Mineral Research, 2025/01/10. Richard Eastell, Jacques P Brown, Robert A Adler, E Michael Lewiecki, Neil Binkley, Eric S Orwoll, David Kendler, Bruce H Mitlak, Yamei Wang. DOI 10.1093/jbmr/zjaf003

Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study Advances in Rheumatology, 2024/08/06. Wen Qi, Antoine Robert, Narcisse Singbo, Lucie Ratelle, Paul R. Fortin, Louis Bessette, Jacques P. Brown, Laëtitia Michou. DOI 10.1186/s42358-024-00396-6

Reconstruction of remodeling units reveals positive effects after 2 and 12 months of romosozumab treatment Journal of Bone and Mineral Research, 2024/07/23. Erik F Eriksen, Rogely W Boyce, Yifei Shi, Jacques P Brown, Donald Betah, Cesar Libanati, Mary Oates, Roland Chapurlat, Pascale Chavassieux. DOI 10.1093/jbmr/zjae055

A novel oral hPTH(1-34) unveils the promise of modeling-based anabolism with no increase in bone remodeling Journal of Bone and Mineral Research, 2024/07/23. Jacques P Brown. DOI 10.1093/jbmr/zjae080

Postfracture survival in a population-based study of adults aged ≥66 yr: a call to action at hospital discharge JBMR Plus, 2024/03/28. Geneviève Vincent, Jonathan D Adachi, Emil Schemitsch, Jean-Eric Tarride, Nathan Ho, Rajvi J Wani, Jacques P Brown. DOI 10.1093/jbmrpl/ziae002

Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study figshare, 2024. Wen Qi, Antoine Robert, Narcisse Singbo, Lucie Ratelle, Paul R. Fortin, Louis Bessette, Jacques P. Brown, Laetitia Michou. DOI 10.6084/m9.figshare.c.7390765.v1

Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study figshare, 2024. Wen Qi, Antoine Robert, Narcisse Singbo, Lucie Ratelle, Paul R. Fortin, Louis Bessette, Jacques P. Brown, Laetitia Michou. DOI 10.6084/m9.figshare.c.7390765

Additional file 1 of Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study figshare, 2024. Wen Qi, Antoine Robert, Narcisse Singbo, Lucie Ratelle, Paul R. Fortin, Louis Bessette, Jacques P. Brown, Laetitia Michou. DOI 10.6084/m9.figshare.26507191

Additional file 1 of Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study figshare, 2024. Wen Qi, Antoine Robert, Narcisse Singbo, Lucie Ratelle, Paul R. Fortin, Louis Bessette, Jacques P. Brown, Laetitia Michou. DOI 10.6084/m9.figshare.26507191.v1

Trends in osteoporotic fracture and related in-hospital complications during the COVID-19 pandemic in Alberta, Canada Archives of Osteoporosis, 2022/12. T. Oliveira, D. L. Kendler, P. Schneider, A. G. Juby, Rajvi Wani, M. Packalen, S. Avcil, S. Li, C. Waters-Banker, E. Graves, S. McMullen, Jacques P. Brown. DOI 10.1007/s11657-022-01114-9

Trends in osteoporosis care patterns during the COVID-19 pandemic in Alberta, Canada Archives of Osteoporosis, 2022/12. T. Oliveira, J. Brown, A. G. Juby, P. Schneider, R. J. Wani, M. Packalen, S. Avcil, S. Li, M. Farris, E. Graves, S. McMullen, D. L. Kendler. DOI 10.1007/s11657-022-01132-7

Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada Archives of Osteoporosis, 2022/12. Ron Goeree, Natasha Burke, Manon Jobin, Jacques P. Brown, Donna Lawrence, Björn Stollenwerk, Damon Willems, Ben Johnson. DOI 10.1007/s11657-022-01106-9

Current use of bone turnover markers in the management of osteoporosis Clinical Biochemistry, 2022/11. Jacques P. Brown, Andrew Don-Wauchope, Pierre Douville, Caroline Albert, Samuel D. Vasikaran. DOI 10.1016/j.clinbiochem.2022.09.002

Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients Osteoporosis International, 2022/01. Emil Schemitsch, Jonathan D. Adachi, Jacques P. Brown, Jean-Eric Tarride, Natasha Burke, Thiago Oliveira, Lubomira Slatkovska. DOI 10.1007/s00198-021-06080-5

Where’s the break? Critique of radiographic vertebral fracture diagnostic methods Osteoporosis International, 2021/12. J. C. Prior, E. H. G. Oei, J. P. Brown, L. Oei, F. Koromani, Brian C. Lentle. DOI 10.1007/s00198-021-06207-8

Romosozumab Improves Lumbar Spine Bone Mass and Bone Strength Parameters Relative to Alendronate in Postmenopausal Women: Results From the ARCH Trial. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2021/06/30. DOI 10.1002/jbmr.4409

Long-Term Treatment of Postmenopausal Osteoporosis. Endocrinology and metabolism (Seoul, Korea), 2021/06/22. DOI 10.3803/enm.2021.301

Fragility fracture identifies patients at imminent risk for subsequent fracture: real-world retrospective database study in Ontario, Canada. BMC musculoskeletal disorders, 2021/02/26. DOI 10.1186/s12891-021-04051-9

Incremental costs of fragility fractures: a population-based matched -cohort study from Ontario, Canada. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2021/02/18. DOI 10.1007/s00198-021-05877-8

Duration-Dependent Increase of Human Bone Matrix Mineralization in Long-Term Bisphosphonate Users with Atypical Femur Fracture. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2021/02/11. DOI 10.1002/jbmr.4244

Mortality in older adults following a fragility fracture: real-world retrospective matched-cohort study in Ontario. BMC musculoskeletal disorders, 2021/01/23. DOI 10.1186/s12891-021-03960-z

Prediction of Osteoporotic Fractures in Elderly Individuals: A Derivation and Internal Validation Study Using Healthcare Administrative Data Journal of Bone and Mineral Research, 2020/12/01. Claudia Beaudoin, Sonia Jean, Lynne Moore, Philippe Gamache, Louis Bessette, Louis-Georges Ste-Marie, Jacques P. Brown. DOI 10.1002/jbmr.4438

Bone Mineral and Organic Properties in Postmenopausal Women Treated With Denosumab for Up to 10 years Journal of Bone and Mineral Research, 2020/12/01. Delphine Farlay, Sébastien Rizzo, David W Dempster, Shuang Huang, Arkadi Chines, Jacques P Brown, Georges Boivin. DOI 10.1002/jbmr.4538

Vertebral Fractures: Which Radiological Criteria Are Better Associated With the Clinical Course of Osteoporosis? Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes, 2020/10/06. DOI 10.1177/0846537120963692

Clinical phenotype of adult offspring carriers of the p.Pro392Leu mutation within the <i>SQSTM1</i> gene in Paget's disease of bone. Bone reports, 2020/09/18. DOI 10.1016/j.bonr.2020.100717

Vertebral Fractures: Which Radiological Criteria Are Better Associated With the Clinical Course of Osteoporosis? Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes, 2020/08/05. DOI 10.1177/0846537120943529

A scorecard for osteoporosis in Canada and seven Canadian provinces. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2020/07/25. DOI 10.1007/s00198-020-05554-2

A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2020/07/04. DOI 10.1007/s00198-020-05502-0